Celularity Total Revenue vs Total Current Liabilities Analysis

CELUW Stock  USD 0.02  0.0004  1.79%   
Celularity financial indicator trend analysis is way more than just evaluating Celularity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Celularity is a good investment. Please check the relationship between Celularity Total Revenue and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Total Revenue vs Total Current Liabilities

Total Revenue vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Celularity Total Revenue account and Total Current Liabilities. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Celularity's Total Revenue and Total Current Liabilities is -0.14. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Celularity, assuming nothing else is changed. The correlation between historical values of Celularity's Total Revenue and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Celularity are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Revenue i.e., Celularity's Total Revenue and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.14
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Revenue

Total revenue comprises all receipts Celularity generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Total Current Liabilities

Total Current Liabilities is an item on Celularity balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Celularity are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Celularity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.Tax Provision is likely to climb to about 10.5 K in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024.
 2021 2023 2024 (projected)
Interest Expense3.2M3.0M2.5M
Depreciation And Amortization51.1M10.8M20.6M

Celularity fundamental ratios Correlations

0.610.820.54-0.080.22-0.680.81.0-0.180.80.560.740.830.27-0.70.81-0.70.410.56-0.090.73-0.810.520.670.79
0.610.460.970.160.77-0.920.230.610.030.540.940.320.60.07-0.910.8-0.910.80.91-0.80.9-0.850.920.180.81
0.820.460.52-0.410.01-0.660.870.780.350.830.390.840.9-0.28-0.680.82-0.680.310.550.010.71-0.820.520.790.8
0.540.970.520.070.72-0.950.240.520.260.550.930.320.62-0.17-0.940.82-0.940.810.94-0.80.93-0.870.950.190.84
-0.080.16-0.410.070.640.08-0.59-0.02-0.41-0.540.36-0.73-0.530.420.13-0.190.130.07-0.11-0.08-0.140.180.02-0.78-0.17
0.220.770.010.720.64-0.5-0.350.25-0.2-0.090.76-0.280.020.25-0.480.32-0.470.480.56-0.630.45-0.380.68-0.40.35
-0.68-0.92-0.66-0.950.08-0.5-0.5-0.66-0.29-0.76-0.9-0.52-0.780.191.0-0.931.0-0.87-0.940.72-1.00.97-0.9-0.4-0.94
0.80.230.870.24-0.59-0.35-0.50.760.170.910.160.940.89-0.1-0.530.7-0.530.230.360.140.56-0.670.240.940.66
1.00.610.780.52-0.020.25-0.660.76-0.230.760.560.70.790.32-0.670.78-0.670.40.54-0.070.7-0.780.50.630.77
-0.180.030.350.26-0.41-0.2-0.290.17-0.230.230.10.150.24-0.99-0.290.28-0.290.240.26-0.170.29-0.290.240.150.28
0.80.540.830.55-0.54-0.09-0.760.910.760.230.460.920.97-0.15-0.790.88-0.790.520.64-0.280.81-0.860.510.870.82
0.560.940.390.930.360.76-0.90.160.560.10.460.140.480.0-0.870.77-0.870.840.83-0.760.86-0.810.850.00.77
0.740.320.840.32-0.73-0.28-0.520.940.70.150.920.140.93-0.09-0.570.69-0.570.240.46-0.010.59-0.680.340.990.66
0.830.60.90.62-0.530.02-0.780.890.790.240.970.480.93-0.15-0.810.9-0.810.470.68-0.260.84-0.890.590.870.85
0.270.07-0.28-0.170.420.250.19-0.10.32-0.99-0.150.0-0.09-0.150.19-0.180.19-0.15-0.170.11-0.190.19-0.16-0.1-0.18
-0.7-0.91-0.68-0.940.13-0.481.0-0.53-0.67-0.29-0.79-0.87-0.57-0.810.19-0.931.0-0.85-0.950.71-1.00.97-0.9-0.45-0.95
0.810.80.820.82-0.190.32-0.930.70.780.280.880.770.690.9-0.18-0.93-0.930.640.77-0.470.95-0.970.720.590.89
-0.7-0.91-0.68-0.940.13-0.471.0-0.53-0.67-0.29-0.79-0.87-0.57-0.810.191.0-0.93-0.85-0.950.7-1.00.98-0.9-0.45-0.95
0.410.80.310.810.070.48-0.870.230.40.240.520.840.240.47-0.15-0.850.64-0.850.89-0.810.82-0.760.850.120.81
0.560.910.550.94-0.110.56-0.940.360.540.260.640.830.460.68-0.17-0.950.77-0.950.89-0.780.92-0.880.980.340.91
-0.09-0.80.01-0.8-0.08-0.630.720.14-0.07-0.17-0.28-0.76-0.01-0.260.110.71-0.470.7-0.81-0.78-0.670.53-0.760.11-0.5
0.730.90.710.93-0.140.45-1.00.560.70.290.810.860.590.84-0.19-1.00.95-1.00.820.92-0.67-0.980.870.480.95
-0.81-0.85-0.82-0.870.18-0.380.97-0.67-0.78-0.29-0.86-0.81-0.68-0.890.190.97-0.970.98-0.76-0.880.53-0.98-0.84-0.57-0.97
0.520.920.520.950.020.68-0.90.240.50.240.510.850.340.59-0.16-0.90.72-0.90.850.98-0.760.87-0.840.210.87
0.670.180.790.19-0.78-0.4-0.40.940.630.150.870.00.990.87-0.1-0.450.59-0.450.120.340.110.48-0.570.210.56
0.790.810.80.84-0.170.35-0.940.660.770.280.820.770.660.85-0.18-0.950.89-0.950.810.91-0.50.95-0.970.870.56
Click cells to compare fundamentals

Celularity Account Relationship Matchups

Celularity fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets291.6M431.0M414.1M401.1M143.9M136.7M
Short Long Term Debt Total28.1M30.6M31.1M65.6M75.4M79.2M
Other Current Liab(3.5M)18.3M11.7M16.4M2.4M2.3M
Total Current Liabilities229.1K26.7M26.2M62.1M67.3M70.7M
Total Stockholder Equity263.4M(531.4M)99.4M198.9M41.0M43.0M
Net Debt27.1M(23.7M)(6.1M)51.6M39.0M41.0M
Retained Earnings3.9M(563.6M)(663.7M)(645.5M)(841.8M)(799.7M)
Cash917.0K54.3M37.2M14.0M227K215.7K
Non Current Assets Total290.6M358.8M376.9M367.6M124.1M117.9M
Non Currrent Assets Other(464.9M)20.1M39.8M23.3M26.9M28.3M
Cash And Short Term Investments917.0K54.3M37.2M14.0M16.1M23.4M
Liabilities And Stockholders Equity291.6M431.0M414.1M401.1M461.2M338.4M
Other Stockholder Equity259.5M32.2M763.1M844.4M971.0M1.0B
Total Liab28.2M962.4M314.7M202.2M102.9M97.8M
Total Current Assets1.0M72.2M37.2M33.5M19.8M30.0M
Common Stock258.4M1K12K15K13.5K12.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.